Corporate Tech Investors

Lyell Immunopharma

Lyell Immunopharma is a corporate VC investing group that makes equity investment in companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Lyell Immunopharma Inc. is a cellular therapy company dedicated to mastering immune cell functionality. We are focused on advancing the science of t-cell differentiation, functionality, and specificity so that we can develop curative treatments for human disease. We are all about the cells.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/1/2021

Transaction History

Our records indicate that Lyell Immunopharma invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Rick Klausner

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Lyell Immunopharma has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

LVMH Moët Hennessy Louis Vuitton | Lyft

Share this article

About Our Corporate Tech Investing Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary